Mohr Davidow Ventures

News, insights, analysis and data

← Back to Mohr Davidow Ventures profile

Mohr Davidow Ventures related stories

All articles and analysis

  • VC-Backed Massive Health Launches “The Eatery”
    VCJ Staff- 2 November 2011

    Massive Health has launched “The Eatery,” a nutrition app for the iPhone that id designed to track and analyze a person’s overall eating patterns. The company, launched this year, is backed by seed financing from venture capital firms Andreessen Horowitz, Charles River Ventures, Greylock Partners, Mohr Davidow Ventures and Felicis Ventures. Massive Health is based in San Francisco.

  • People Briefs, November 2011
    VCJ Staff- 1 November 2011

    Personnel changes at TCV, Highland, Mayfield and other U.S.-based VC firms

  • ZeaChem Adds Two Heavy Hitters to Board
    VCJ Staff- 25 October 2011
  • Calendar
    Brad Meikle- 1 October 2011
  • Few Complete IPOs, But Many File
    Staff Writer- 1 October 2011

    Jive Software, Brightcove among the recent companies that filed to go public

  • Kai-Fu Lee Wraps up Fund from All-Star Cast
    Staff Writer- 1 October 2011

    Yuri Milner, Ron Conway, Sequoia and others fill out the LP roster in the Innovation Works fund

  • Visible Measures Picks Up $13M
    VCJ Staff- 22 September 2011

    Visible Measures, maker of an analytics and advertising platform for social video, has raised $13 million in a round led by DAG Ventures. The Series D round also included an investment from Advance Publications Inc. – owners of magazine giant Conde Nast – along with participation from existing investors General Catalyst Partners, Mohr Davidow Ventures, and Northgate Capital.

  • Crescendo Bioscience Closes on $56M
    VCJ Staff- 9 September 2011

    Crescendo Bioscience, a molecular diagnostics company developing quantitative biomarker tests for rheumatoid arthritis and other diseases, has raised a total of $56 million in fresh capital. The company inked $31 million in Series C financing, and sealed a strategic investment agreement with Myriad Genetics for $25 million. Venture investors include Aeris Capital, Mohr Davidow Ventures and Kleiner Perkins Caufield & Byers. The $25 million investment by Myriad Genetics is structured as long-term debt with a three-year option to acquire Crescendo Bioscience.

  • Calendar
    Brad Meikle- 1 September 2011